• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

绝经后女性的心血管疾病风险

Cardiovascular Disease Risk in Women with Menopause.

作者信息

Fasero María, Coronado Pluvio J

机构信息

Department of Obstetrics and Gynecology, Menopause Unit, Hospital de la Zarzuela, 28023 Madrid, Spain.

Clínica Corofas Menopause, 13700 Tomelloso, Spain.

出版信息

J Clin Med. 2025 May 23;14(11):3663. doi: 10.3390/jcm14113663.

DOI:10.3390/jcm14113663
PMID:40507425
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12156203/
Abstract

: Menopause is a significant physiological milestone in a woman's life, coinciding with increased cardiovascular disease (CVD) risk due to various health-related changes. This narrative review focuses on cardiovascular health-related alterations during menopause and their implications on vascular function. : An electronic database search was performed, drawing from sources such as PubMed and Google Scholar. Publications were included if they addressed CVD risk in peri- and postmenopausal women, and examined the impact of hormonal changes, traditional risk factors (e.g., hypertension, hyperlipidemia, diabetes), or lifestyle factors (e.g., diet, physical activity) on CVD. : Estrogen deficiency is pivotal, leading to adverse effects such as endothelial dysfunction, increased arterial stiffness, and lipid profile deterioration. Characteristics of menopause, including the age at onset, type or stage of menopause, and severity of symptoms, further modulate CVD risk. Additionally, the impact of traditional risk factors is amplified during this period. Strategies for the prevention of CVD in menopausal women are critically assessed, with a focus on lifestyle modifications, dietary interventions, and physical activity. : This narrative review describes the potential benefits and risks of hormone therapy, alongside lipid-lowering therapies. Emphasis is placed on individualized risk assessment and management, highlighting the need for regular cardiovascular screenings and proactive management of risk factors.

摘要

绝经是女性生命中的一个重要生理里程碑,在此期间,由于各种与健康相关的变化,心血管疾病(CVD)风险增加。本叙述性综述聚焦于绝经期间与心血管健康相关的变化及其对血管功能的影响。通过从PubMed和谷歌学术等来源进行电子数据库搜索。如果出版物涉及绝经前后女性的CVD风险,并研究了激素变化、传统风险因素(如高血压、高脂血症、糖尿病)或生活方式因素(如饮食、体育活动)对CVD的影响,则将其纳入。雌激素缺乏至关重要,会导致诸如内皮功能障碍、动脉僵硬度增加和血脂恶化等不良影响。绝经的特征,包括开始年龄、绝经类型或阶段以及症状严重程度,会进一步调节CVD风险。此外,在此期间传统风险因素的影响会放大。对绝经后女性预防CVD的策略进行了严格评估,重点是生活方式改变、饮食干预和体育活动。本叙述性综述描述了激素疗法以及降脂疗法的潜在益处和风险。强调个体化风险评估和管理,突出定期心血管筛查和积极管理风险因素的必要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dae/12156203/ba1262861922/jcm-14-03663-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dae/12156203/ba1262861922/jcm-14-03663-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dae/12156203/ba1262861922/jcm-14-03663-g001.jpg

相似文献

1
Cardiovascular Disease Risk in Women with Menopause.绝经后女性的心血管疾病风险
J Clin Med. 2025 May 23;14(11):3663. doi: 10.3390/jcm14113663.
2
The route of administration, timing, duration and dose of postmenopausal hormone therapy and cardiovascular outcomes in women: a systematic review.绝经后激素治疗的给药途径、时间、持续时间和剂量与女性心血管结局:系统评价。
Hum Reprod Update. 2019 Mar 1;25(2):257-271. doi: 10.1093/humupd/dmy039.
3
[Is menopause a risk factor for ischemic heart disease in women?].[绝经是女性缺血性心脏病的危险因素吗?]
G Ital Cardiol (Rome). 2012 Jun;13(6):401-6. doi: 10.1714/1073.11757.
4
Menopause-related changes in vascular signaling by sex hormones.性激素导致的与更年期相关的血管信号变化。
J Pharmacol Exp Ther. 2025 Apr;392(4):103526. doi: 10.1016/j.jpet.2025.103526. Epub 2025 Mar 4.
5
Hormone therapy in the postmenopausal years: considering benefits and risks in clinical practice.绝经期后激素治疗:在临床实践中考虑获益与风险。
Hum Reprod Update. 2021 Oct 18;27(6):1115-1150. doi: 10.1093/humupd/dmab026.
6
Management of postmenopausal women: Collège National des Gynécologues et Obstétriciens Français (CNGOF) and Groupe d'Etude sur la Ménopause et le Vieillissement (GEMVi) Clinical Practice Guidelines.绝经后女性管理:法国妇产科学院(CNGOF)和绝经与衰老研究小组(GEMVi)临床实践指南。
Maturitas. 2022 Sep;163:62-81. doi: 10.1016/j.maturitas.2022.05.008. Epub 2022 Jun 9.
7
Understanding of and clinical approach to cardiometabolic transition at the menopause.绝经相关心代谢转换的理解与临床对策。
Climacteric. 2024 Feb;27(1):68-74. doi: 10.1080/13697137.2023.2202809. Epub 2023 May 24.
8
Dyslipidemia in midlife women: Approach and considerations during the menopausal transition.中年女性血脂异常:绝经过渡期间的处理方法及注意事项
Maturitas. 2022 Dec;166:14-20. doi: 10.1016/j.maturitas.2022.08.001. Epub 2022 Aug 11.
9
Cardiovascular and physiological risk factors in women at mid-life and beyond.中年及以后女性的心血管和生理风险因素。
Can J Physiol Pharmacol. 2024 Aug 1;102(8):442-451. doi: 10.1139/cjpp-2023-0468. Epub 2024 May 13.
10
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON MENOPAUSE-2017 UPDATE.美国临床内分泌医师协会和美国内分泌学会关于绝经的立场声明 - 2017年更新版
Endocr Pract. 2017 Jul;23(7):869-880. doi: 10.4158/EP171828.PS.

引用本文的文献

1
Lipid-Modulating Effects of Fermented by KCCM12759P and KCCM12756P in Ovariectomized Mice.KCCM12759P和KCCM12756P发酵物对去卵巢小鼠的脂质调节作用
Nutrients. 2025 Jul 31;17(15):2527. doi: 10.3390/nu17152527.

本文引用的文献

1
Predictive biomarkers for cardiometabolic risk in postmenopausal women: insights into visfatin, adropin, and adiponectin.绝经后女性心脏代谢风险的预测生物标志物:对内脂素、内泌素和脂联素的见解
Front Endocrinol (Lausanne). 2025 Feb 7;16:1527567. doi: 10.3389/fendo.2025.1527567. eCollection 2025.
2
Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women.炎症、胆固醇、脂蛋白(a)与女性30年心血管结局
N Engl J Med. 2024 Dec 5;391(22):2087-2097. doi: 10.1056/NEJMoa2405182. Epub 2024 Aug 31.
3
Pulse Wave Velocity: Methodology, Clinical Applications, and Interplay with Heart Rate Variability.
脉搏波速度:方法学、临床应用及其与心率变异性的相互作用
Rev Cardiovasc Med. 2024 Jul 17;25(7):266. doi: 10.31083/j.rcm2507266. eCollection 2024 Jul.
4
Reproductive factors and risk of cardiovascular diseases and all-cause and cardiovascular mortality in American women: NHANES 2003-2018.美国女性生殖因素与心血管疾病及全因和心血管死亡率的关系:NHANES 2003-2018 年。
BMC Womens Health. 2024 Apr 5;24(1):222. doi: 10.1186/s12905-024-03055-6.
5
Sex- and gender-related disparities in chest pain syndromes: the feminine mystique of chest pain.胸痛综合征中的性别相关差异:胸痛的女性神秘主义。
Curr Probl Cardiol. 2024 Apr;49(4):102457. doi: 10.1016/j.cpcardiol.2024.102457. Epub 2024 Feb 9.
6
The importance of female reproductive history on self-reported sleep quality, mood, and urogenital symptoms in midlife.女性生殖史对中年女性自报告睡眠质量、情绪和泌尿生殖系统症状的重要性。
Menopause. 2023 Nov 1;30(11):1157-1166. doi: 10.1097/GME.0000000000002277.
7
Lipoprotein(a) as a Risk Factor for Cardiovascular Diseases: Pathophysiology and Treatment Perspectives.脂蛋白(a)作为心血管疾病的危险因素:病理生理学和治疗观点。
Int J Environ Res Public Health. 2023 Sep 6;20(18):6721. doi: 10.3390/ijerph20186721.
8
Early elevation of high-sensitivity C-reactive protein as a predictor for cardiovascular disease incidence and all-cause mortality: a landmark analysis.早期高敏 C 反应蛋白升高可预测心血管疾病发病率和全因死亡率:里程碑式分析。
Sci Rep. 2023 Aug 29;13(1):14118. doi: 10.1038/s41598-023-41081-w.
9
The joint effect of gestational diabetes mellitus and hypertension contribute to higher risk of diabetes mellitus after delivery: a nationwide population-based study.妊娠糖尿病和高血压的共同作用增加了产后发生糖尿病的风险:一项全国性基于人群的研究。
BMC Pregnancy Childbirth. 2023 Jul 26;23(1):539. doi: 10.1186/s12884-023-05829-6.
10
Effect of resistance training on lipid profile in postmenopausal women: A systematic review and meta-analysis of randomized controlled trials.抗阻训练对绝经后妇女血脂谱的影响:系统评价和随机对照试验的荟萃分析。
Eur J Obstet Gynecol Reprod Biol. 2023 Sep;288:18-28. doi: 10.1016/j.ejogrb.2023.06.023. Epub 2023 Jun 24.